“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...

Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, discusses challenges such as high costs and long ...